Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMX-010 in Islet Transplantation
NCT02457858Phase 1Completed
- Sponsor
- University of Alberta
- Start
- Aug 2014
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label trial of BMX-010 in type 1 diabetes mellitus (T1D), sponsored by University of Alberta. Primary endpoint: Islet yield using BMX-010. Started Aug 2014; status: completed.
02
Drugs
BMX-010
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02457858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457858.